HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ: 052260)

Market Cap	153.30B
Revenue (ttm)	114.69B
Net Income (ttm)	8.29B
Shares Out	30.00M
EPS (ttm)	276.32
PE Ratio	18.49
Forward PE	14.16
Dividend	35.00 (0.68%)
Ex-Dividend Date	n/a

Volume	91,935
Open	5,120.00
Previous Close	5,120.00
Day's Range	5,090.00 - 5,250.00
52-Week Range	4,480.00 - 12,630.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About HYUNDAI BIOLAND Co.,Ltd.

HYUNDAI BIOLAND Co.,Ltd. engages in the manufacture and sale of natural materials for cosmetics, nutraceuticals, and regenerative medicines worldwide. The company’s cosmetics includes whitening, skin protection, moisturizing, anti-aging, sheet mask, and hair and body care products; and functional food ingredients comprising various nutraceuticals and general food raw ingredients. It is also involved in the provision of medical biomedical materials for dental, wound, orthopedic, and biomaterial applications; and manufacture and supply of active ...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 320
• Stock Exchange: KOSDAQ
• Ticker Symbol: 052260

Financial Performance

In 2023, HYUNDAI BIOLAND Co.,Ltd.'s revenue was 101.69 billion, an increase of 2.56% compared to the previous year's 99.15 billion. Earnings were 8.06 billion, an increase of 69.09%.